FOX-2 dependent splicing of ataxin-2 transcript is affected by ataxin-1 overexpression

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Welzel, Franziska ^a,b   Kaehler, Christian ^a,b   Isau, Melanie ^a,b   Hallen, Linda ^a   Lehrach, Hans ^a   Krobitsch, Sylvia ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; ATAXIN 2; MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; PROTEIN FOX 2; UNCLASSIFIED DRUG; ATAXIN-1; ISOPROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; RBFOX2 PROTEIN, HUMAN; REPRESSOR PROTEIN; RNA BINDING PROTEIN; SCA2 PROTEIN;

ARTICLE; CONTROLLED STUDY; EXON; GENE OVEREXPRESSION; HUMAN; IMMUNOPRECIPITATION; MAMMAL CELL; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA SPLICING; TWO HYBRID SYSTEM; ALTERNATIVE RNA SPLICING; CELL NUCLEUS; CELL STRAIN HEK293; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT;

MAMMALIA;

ALTERNATIVE SPLICING; CELL NUCLEUS; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HUMANS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN TRANSPORT; REPRESSOR PROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84861644135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037985     Document Type: Article

References (66)

1. Blencowe BJ, (2006) Alternative splicing: new insights from global analyses. Cell 126: 37-47.
2. Graveley BR, (2001) Alternative splicing: increasing diversity in the proteomic world. Trends Genet 17: 100-107.
3. Wang GS, Cooper TA, (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8: 749-761.
4. Caceres JF, Stamm S, Helfman DM, Krainer AR, (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265: 1706-1709.
5. Lopez-Bigas N, Audit B, Ouzounis C, Parra G, Guigo R, (2005) Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett 579: 1900-1903.
6. Kuroyanagi H, (2009) Fox-1 family of RNA-binding proteins. Cell Mol Life Sci 66: 3895-3907.
7. Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL, (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol Cell Biol 25: 10005-10016.
8. Nakahata S, Kawamoto S, (2005) Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res 33: 2078-2089.
9. Zhang C, Zhang Z, Castle J, Sun S, Johnson J, et al. (2008) Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev 22: 2550-2563.
10. Yeo GW, Coufal NG, Liang TY, Peng GE, Fu XD, et al. (2009) An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol 16: 130-137.
11. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, et al. (2007) Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet 144B: 869-876.
12. Lale S, Yu S, Ahmed A, (2011) Complex Congenital Heart Defects in Association with Maternal Diabetes and Partial Deletion of the A2BP1 Gene. Fetal Pediatr Pathol.
13. Hamshere ML, Green EK, Jones IR, Jones L, Moskvina V, et al. (2009) Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. Br J Psychiatry 195: 23-29.
14. Jiang W, Li X, Rao S, Wang L, Du L, et al. (2008) Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements. BMC Syst Biol 2: 72.
15. Li C, Kato M, Shiue L, Shively JE, Ares M Jr, et al. (2006) Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Res 66: 1990-1999.
16. Lim J, Hao T, Shaw C, Patel AJ, Szabo G, et al. (2006) A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125: 801-814.
17. Reddy PS, Housman DE, (1997) The complex pathology of trinucleotide repeats. Curr Opin Cell Biol 9: 364-372.
18. Truant R, Raymond LA, Xia J, Pinchev D, Burtnik A, et al. (2006) Canadian Association of Neurosciences Review: polyglutamine expansion neurodegenerative diseases. Can J Neurol Sci 33: 278-291.
19. Zoghbi HY, Orr HT, (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23: 217-247.
20. Banfi S, Servadio A, Chung MY, Kwiatkowski TJ Jr, McCall AE, et al. (1994) Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet 7: 513-520.
21. Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, et al. (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4: 221-226.
22. Zoghbi HY, Orr HT, (2009) Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem 284: 7425-7429.
23. Kang S, Hong S, (2009) Molecular pathogenesis of spinocerebellar ataxia type 1 disease. Mol Cells 27: 621-627.
24. Matilla-Duenas A, Goold R, Giunti P, (2008) Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1. Cerebellum 7: 106-114.
25. Irwin S, Vandelft M, Pinchev D, Howell JL, Graczyk J, et al. (2005) RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci 118: 233-242.
26. de Chiara C, Menon RP, Strom M, Gibson TJ, Pastore A, (2009) Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors. PLoS One 4: e8372.
27. Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, et al. (2008) Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 452: 713-718.
28. Al-Ramahi I, Perez AM, Lim J, Zhang M, Sorensen R, et al. (2007) dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. PLoS Genet 3: e234.
29. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, et al. (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389: 971-974.
30. Kim SJ, Kim TS, Kim IY, Hong S, Rhim H, et al. (2003) Polyglutamine-expanded ataxin-1 recruits Cu/Zn-superoxide dismutase into the nucleus of HeLa cells. Biochem Biophys Res Commun 307: 660-665.
31. Shibata H, Huynh DP, Pulst SM, (2000) A novel protein with RNA-binding motifs interacts with ataxin-2. Hum Mol Genet 9: 1303-1313.
32. Lukong KE, Chang KW, Khandjian EW, Richard S, (2008) RNA-binding proteins in human genetic disease. Trends Genet 24: 416-425.
33. Branco J, Al-Ramahi I, Ukani L, Perez AM, Fernandez-Funez P, et al. (2008) Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum Mol Genet 17: 376-390.
34. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, et al. (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408: 101-106.
35. de Chiara C, Giannini C, Adinolfi S, de Boer J, Guida S, et al. (2003) The AXH module: an independently folded domain common to ataxin-1 and HBP1. FEBS Lett 551: 107-112.
36. de Chiara C, Menon RP, Dal Piaz F, Calder L, Pastore A, (2005) Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein. J Mol Biol 354: 883-893.
37. Lee JA, Tang ZZ, Black DL, (2009) An inducible change in Fox-1/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons. Genes Dev 23: 2284-2293.
38. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, et al. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95: 41-53.
39. Dember LM, Kim ND, Liu KQ, Anderson P, (1996) Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. J Biol Chem 271: 2783-2788.
40. Le Guiner C, Lejeune F, Galiana D, Kister L, Breathnach R, et al. (2001) TIA-1 and TIAR activate splicing of alternative exons with weak 5′ splice sites followed by a U-rich stretch on their own pre-mRNAs. J Biol Chem 276: 40638-40646.
41. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, et al. (2008) miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 11: 1137-1139.
42. Rich T, Varadaraj A, (2007) Ataxin-1 fusion partners alter polyQ lethality and aggregation. PLoS One 2: e1014.
43. Tsai CC, Kao HY, Mitzutani A, Banayo E, Rajan H, et al. (2004) Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc Natl Acad Sci U S A 101: 4047-4052.
44. Ralser M, Albrecht M, Nonhoff U, Lengauer T, Lehrach H, et al. (2005) An integrative approach to gain insights into the cellular function of human ataxin-2. J Mol Biol 346: 203-214.
45. Anderson P, Kedersha N, (2006) RNA granules. J Cell Biol 172: 803-808.
46. Kedersha NL, Gupta M, Li W, Miller I, Anderson P, (1999) RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol 147: 1431-1442.
47. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
48. Yue S, Serra HG, Zoghbi HY, Orr HT, (2001) The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum Mol Genet 10: 25-30.
49. Gottschalk A, Tang J, Puig O, Salgado J, Neubauer G, et al. (1998) A comprehensive biochemical and genetic analysis of the yeast U1 snRNP reveals five novel proteins. RNA 4: 374-393.
50. Corsini L, Bonnal S, Basquin J, Hothorn M, Scheffzek K, et al. (2007) U2AF-homology motif interactions are required for alternative splicing regulation by SPF45. Nat Struct Mol Biol 14: 620-629.
51. Nonhoff U, Ralser M, Welzel F, Piccini I, Balzereit D, et al. (2007) Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell 18: 1385-1396.
52. Lastres-Becker I, Rub U, Auburger G, (2008) Spinocerebellar ataxia 2 (SCA2). Cerebellum 7: 115-124.
53. Affaitati A, de Cristofaro T, Feliciello A, Varrone S, (2001) Identification of alternative splicing of spinocerebellar ataxia type 2 gene. Gene 267: 89-93.
54. Sahba S, Nechiporuk A, Figueroa KP, Nechiporuk T, Pulst SM, (1998) Genomic structure of the human gene for spinocerebellar ataxia type 2 (SCA2) on chromosome 12q24.1. Genomics 47: 359-364.
55. Neuwald AF, Koonin EV, (1998) Ataxin-2, global regulators of bacterial gene expression, and spliceosomal snRNP proteins share a conserved domain. J Mol Med 76: 3-5.
56. Hallen L, Klein H, Stoschek C, Wehrmeyer S, Nonhoff U, et al. (2011) The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2. Hum Mol Genet 20: 104-114.
57. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, et al. (2005) Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122: 379-391.
58. Konig H, Matter N, Bader R, Thiele W, Muller F, (2007) Splicing segregation: the minor spliceosome acts outside the nucleus and controls cell proliferation. Cell 131: 718-729.
59. Delestienne N, Wauquier C, Soin R, Dierick JF, Gueydan C, et al. (2010) The splicing factor ASF/SF2 is associated with TIA-1-related/TIA-1-containing ribonucleoproteic complexes and contributes to post-transcriptional repression of gene expression. FEBS J 277: 2496-2514.
60. Papin C, Rouget C, Mandart E, (2008) Xenopus Rbm9 is a novel interactor of XGld2 in the cytoplasmic polyadenylation complex. FEBS J 275: 490-503.
61. Harris GM, Dodelzon K, Gong L, Gonzalez-Alegre P, Paulson HL, (2010) Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties. PLoS One 5: e13695.
62. Bettencourt C, Santos C, Montiel R, Costa Mdo C, Cruz-Morales P, et al. (2010) Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3). Neurogenetics 11: 193-202.
63. Goto J, Watanabe M, Ichikawa Y, Yee SB, Ihara N, et al. (1997) Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci Res 28: 373-377.
64. Tsunemi T, Ishikawa K, Jin H, Mizusawa H, (2008) Cell-type-specific alternative splicing in spinocerebellar ataxia type 6. Neurosci Lett 447: 78-81.
65. Einum DD, Clark AM, Townsend JJ, Ptacek LJ, Fu YH, (2003) A novel central nervous system-enriched spinocerebellar ataxia type 7 gene product. Arch Neurol 60: 97-103.
66. Ralser M, Nonhoff U, Albrecht M, Lengauer T, Wanker EE, et al. (2005) Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Hum Mol Genet 14: 2893-2909.